Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
Department of Biostatistics and Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, Iran.
Antimicrob Resist Infect Control. 2023 Jan 29;12(1):4. doi: 10.1186/s13756-023-01210-6.
Methicillin-resistant Staphylococcus aureus (MRSA) is a difficult to treat infection, particularly in residents of elderly care centers (ECCs). Despite the substantial burden of MRSA, an inadequate number of studies have analyzed MRSA prevalence in ECCs.
We conducted a worldwide systematic review and meta-analysis on the prevalence and risk factors of MRSA in ECCs.
We searched MEDLINE/PubMed, EMBASE, Web of Science, and Scopus databases and the gray literature sources for all studies published between January 1980 and December 2022 on the prevalence of MRSA in ECCs. A random-effects model was utilized to estimate pooled prevalence rates at 95% confidence intervals (CI). Moreover, the data were analyzed based on World Health Organization-defined regions, income, and human development index levels.
In total, 119 studies, including 164,717 participants from 29 countries, were found eligible for meta-analysis. The pooled global prevalence of MRSA was 14.69% (95% CI 12.39-17.15%; 16,793/164,717). Male gender [prevalence ratio (PR) = 1.55; 95% CI 1.47-1.64], previous MRSA infection (PR = 3.71; 95% CI 3.44-4.01), prior use of antibiotics (PR = 1.97; 95% CI 1.83-2.12), hospitalized within the previous year (PR = 1.32; 95% CI 1.20-1.45), have had any wound (PR = 2.38; 95% CI 2.23-2.55), have used urinary catheter (PR = 2.24; 95% CI 2.06-2.43), have used any medical device (PR = 1.78; 95% CI 1.66-1.91), and those with diabetes (PR = 1.55; CI 1.43-1.67) were more likely to be colonized by MRSA than other patients.
Screening programs and preventive measures should target MRSA in ECCs due to the high global prevalence rates.
耐甲氧西林金黄色葡萄球菌(MRSA)是一种难以治疗的感染,尤其是在老年护理中心(ECC)的居民中。尽管 MRSA 带来了巨大的负担,但仍有相当数量的研究分析了 ECC 中 MRSA 的流行情况。
我们进行了一项全球性的系统回顾和荟萃分析,以研究 ECC 中 MRSA 的流行率和危险因素。
我们检索了 MEDLINE/PubMed、EMBASE、Web of Science 和 Scopus 数据库以及所有 1980 年 1 月至 2022 年 12 月间发表的关于 ECC 中 MRSA 流行率的灰色文献来源。使用随机效应模型估计 95%置信区间(CI)的汇总流行率。此外,还根据世界卫生组织定义的区域、收入和人类发展指数水平对数据进行了分析。
共发现 119 项研究符合纳入标准,这些研究共纳入了来自 29 个国家的 164717 名参与者。MRSA 的全球总体流行率为 14.69%(95%CI 12.39-17.15%;16793/164717)。男性(比值比[PR] = 1.55;95%CI 1.47-1.64)、既往 MRSA 感染(PR = 3.71;95%CI 3.44-4.01)、既往使用抗生素(PR = 1.97;95%CI 1.83-2.12)、前一年住院(PR = 1.32;95%CI 1.20-1.45)、有任何伤口(PR = 2.38;95%CI 2.23-2.55)、使用导尿管(PR = 2.24;95%CI 2.06-2.43)、使用任何医疗器械(PR = 1.78;95%CI 1.66-1.91)和患有糖尿病(PR = 1.55;CI 1.43-1.67)的患者比其他患者更容易被 MRSA 定植。
鉴于全球高流行率,ECC 中应针对 MRSA 开展筛查计划和预防措施。